AFL
Aflac Incorporated NYSE$112.88
Mkt Cap $60.1B
52w Low $96.95
71.2% of range
52w High $119.32
50d MA $111.42
200d MA $109.35
P/E (TTM)
16.4x
EV/EBITDA
11.0x
P/B
2.0x
Debt/Equity
0.3x
ROE
12.4%
P/FCF
22.9x
RSI (14)
—
ATR (14)
—
Beta
0.65
50d MA
$111.42
200d MA
$109.35
Avg Volume
2.3M
About
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segm…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | 1.79 | 1.75 | -2.2% | 116.21 | -3.4% | -2.2% | -2.9% | — | — | — | — | — |
| Feb 4, 2026 | AMC | 1.69 | 1.57 | -7.1% | 113.62 | -1.0% | +3.4% | +3.1% | -0.4% | +2.0% | +2.3% | -2.1% | — |
| Nov 4, 2025 | AMC | 1.77 | 2.49 | +40.7% | 108.81 | +1.8% | +2.2% | +4.5% | +4.9% | +4.4% | +4.6% | +0.4% | — |
| Aug 5, 2025 | AMC | 1.70 | 1.78 | +4.7% | 98.92 | +2.6% | +3.4% | +3.4% | +4.7% | +5.3% | +4.7% | +9.7% | — |
| Apr 30, 2025 | AMC | 1.67 | 1.66 | -0.6% | 108.68 | -2.9% | -4.7% | -2.9% | -2.7% | -2.6% | -1.6% | -4.7% | — |
| Feb 5, 2025 | AMC | 1.62 | 1.56 | -3.7% | 107.29 | -0.9% | -3.9% | -3.5% | -4.4% | -4.0% | -4.1% | +1.0% | — |
| Oct 30, 2024 | AMC | 1.69 | 2.16 | +27.8% | 110.09 | -2.6% | -4.8% | -4.9% | -5.1% | -4.1% | -1.4% | +3.6% | — |
| Jul 31, 2024 | AMC | 1.60 | 1.83 | +14.4% | 95.38 | +9.4% | +6.6% | +4.0% | +1.9% | +3.4% | +4.1% | +15.7% | — |
| May 1, 2024 | AMC | 1.58 | 1.66 | +5.1% | 84.57 | -1.0% | -0.6% | -1.6% | +0.2% | +0.1% | +0.3% | +6.3% | — |
| Jan 31, 2024 | AMC | 1.45 | 1.25 | -13.8% | 84.34 | -6.5% | -9.7% | -8.9% | -9.5% | -8.8% | -6.5% | -4.6% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Piper Sandler | Maintains | Overweight → Overweight | — | $113.67 | $113.85 | +0.2% | -0.7% | — | — | — | — |
| Apr 30 | Barclays | Maintains | Underweight → Underweight | — | $116.21 | $112.27 | -3.4% | -2.2% | -2.9% | — | — | — |
| Apr 13 | Mizuho | Maintains | Underperform → Underperform | — | $110.70 | $109.68 | -0.9% | +1.3% | +1.1% | +2.1% | +2.7% | +3.5% |
| Apr 10 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $113.07 | $113.08 | +0.0% | -2.1% | -0.8% | -1.0% | -0.1% | +0.6% |
| Apr 10 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $113.07 | $113.08 | +0.0% | -2.1% | -0.8% | -1.0% | -0.1% | +0.6% |
| Apr 9 | UBS | Maintains | Neutral → Neutral | — | $113.00 | $112.50 | -0.4% | +0.1% | -2.0% | -0.8% | -0.9% | -0.0% |
| Feb 25 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $112.46 | $112.59 | +0.1% | -0.0% | +1.3% | +0.4% | +0.8% | -0.0% |
| Jan 8 | Barclays | Maintains | Underweight → Underweight | — | $110.19 | $110.14 | -0.0% | +0.1% | -0.9% | -1.2% | -2.0% | -0.0% |
| Jan 5 | JP Morgan | Maintains | Neutral → Neutral | — | $110.24 | $109.30 | -0.9% | +1.8% | +1.6% | -0.0% | +0.0% | -0.9% |
| Dec 30 | Raymond James | Maintains | Outperform → Outperform | — | $109.96 | $110.08 | +0.1% | +0.8% | +0.3% | +0.3% | +2.0% | +1.8% |
Recent Filings
Data updated apr 24, 2026 4:25pm
· Source: massive.com